GlassScriptPhysician profile
Tae Y Lee
NPI 1821014879
$905.11
in general payments reported to CMS, 2019-2025
9 companies · $23.06 in 2025
The $23.06 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $110 · 2021: $504 · 2022: $74.79 · 2023: $39.85 · 2025: $23.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $357.48 | 2021 | |
| Fresenius USA Marketing, INC. | $141.06 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $109.76 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.99 | 2021 | |
| Nxstage Medical, INC. | $74.79 | 2022 | |
| Glaxosmithkline, LLC. | $39.85 | 2023 | Benlysta |
| Allergan, INC. | $32.22 | 2019 | |
| Baxter Healthcare | $30.90 | 2021 | |
| Vertical Pharmaceuticals, LLC | $23.06 | 2025 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tae Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.